From gastric to neuroprotection: pantoprazole mitigates epilepsy via TrkB/BDNF and KCC2 modulation
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 13275-13292
DOI: 10.1007/s00210-026-05204-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 24.03.2026. Verfasst von Arya Kuhu Vishwapriya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Banasthali Vidyapith, Banasthali, 304022, Rajasthan, India. Hauptthemen laut MEDLINE: Receptor, trkB, Pantoprazole, Brain-Derived Neurotrophic Factor, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Epilepsy is generally described as a pathology resulting from an imbalance between excitatory and inhibitory activities. In recent years, neurotrophins have been recognized as key players in the pathophysiology of nervous system diseases. One such neurotrophin, BDNF, and its receptor, TrkB, play critical roles as epileptogenic factors that regulate neuronal hyperexcitability and synaptic plasticity. In this study, we sought to elucidate the exact mechanisms underlying the neuroprotective and antiepileptic effects of pantoprazole. The molecular docking study indicated key interactions of pantoprazole with the TrkB receptor (PDB ID: 4AT3). Furthermore, pantoprazole exhibited notable in vitro TrkB kinase inhibitory activity (IC50 = 24.01 nM) and good cell viability (% viability = 0.0625 mg/ml) against SH-SY5Y cells. Additionally, the protective effects of pantoprazole were assessed in a total oxidative status study, in which PTZ-induced oxidative stress was reduced by ~ 60%. Subsequent observations in the PTZ-induced epilepsy mouse model demonstrated that pantoprazole (5 mg/kg and 10 mg/kg; p.o.; OD) suppresses seizure severity and anxiety-like behavior while enhancing working memory in a dose-dependent manner. Furthermore, a significant increase in antioxidant enzymes such as catalase, reduced glutathione (GSH), and DNA levels, along with degradation of by-products of lipid peroxidation, malondialdehyde (MDA), nitric oxide, and myeloperoxidase (MPO), responsible for causing oxidative stress during epilepsy, occurred after pantoprazole treatment in the PTZ model. The therapy with pantoprazole also increased the mRNA expression of downregulated KCC2 and thereby restored GABAergic inhibition in the synapse and suppressed epilepsy. Together, these findings indicate that pantoprazole exhibits promising neuroprotective and antiepileptic effects via modulation of the TrkB/BDNF pathway and warrant further exploration in clinical subjects for its translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Banasthali Vidyapith, Banasthali, 304022, Rajasthan, India.
- Department of Bioscience and Biotechnology, Banasthali Vidyapith, Banasthali, 304022, Rajasthan, India.
- School of Pharmacy & Technology Management, SVKM's NMIMS, Shirpur, 425405, Maharashtra, India.
- Department of Chemistry, Banasthali Vidyapith, Banasthali, 304022, Rajasthan, India.
- Department of Pharmacy, Banasthali Vidyapith, Banasthali, 304022, Rajasthan, India. skspharmacology@gmail.com.
Zitieren
APA
Vishwapriya, A. K., Verma, K., Sharma, G., Sindhu, N., Paliwal, S., Jain, S., Dwivedi, J., Paliwal, S., & Sharma, S. (2026). From gastric to neuroprotection: pantoprazole mitigates epilepsy via TrkB/BDNF and KCC2 modulation. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 13275-13292. https://doi.org/10.1007/s00210-026-05204-0
Vancouver
Vishwapriya AK, Verma K, Sharma G, Sindhu N, Paliwal S, Jain S, et al. From gastric to neuroprotection: pantoprazole mitigates epilepsy via TrkB/BDNF and KCC2 modulation. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):13275-13292. doi:10.1007/s00210-026-05204-0
BibTeX
@article{Vishwapriya2026,
author = {Vishwapriya, Arya Kuhu and Verma, Kamini and Sharma, Garima and Sindhu, Nitika and Paliwal, Swati and Jain, Smita and Dwivedi, Jaya and Paliwal, Sarvesh and Sharma, Swapnil},
title = {From gastric to neuroprotection: pantoprazole mitigates epilepsy via TrkB/BDNF and KCC2 modulation},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {9},
pages = {13275--13292},
doi = {10.1007/s00210-026-05204-0}
}
EUVIMED